Home > News > Old Company Press Releases > Quantum Dot News
SC Biosciences Corporation and Quantum Dot Corporation Announce Strategic Partnership
Tokyo, Japan and Hayward, CA. February 25th, 2003
SC BioSciences Corporation (SCB) and Quantum Dot Corporation (QDC), announced today the closing of a major strategic partnership. SCB will immediately commence distribution of Qdot™ nanocrystal products in Japan. SCB will also act as QDC’s exclusive agent for commercial activities in Japan. In addition, SCB will make an equity investment in QDC.
“We are very excited to have the opportunity to work with QDC. For sometime now, we have followed the scientific development of Qdot™ technology. Now we see that the technology is a commercial reality, we are very happy to commit to a close partnership with QDC,” stated Toru Umehara, SCB’s President and CEO. “We are looking forward to working closely with our customers in Japan – we are sure they will realize the significant benefits Qdot™ products bring to biological detection. We also believe that there are significant corporate partnering opportunities for QDC in Japan,” continued Mr. Umehara.
Reprinted with premission. Copyright Quantum Dot Corporation and SC BioSciences Corporation
“We have now launched two different Qdot™ products, with many more planned for 2003. In the two months since our first product launch, we have received extremely positive feedback from our customers. We are confident in SCB’s ability to provide first class support to Qdot product customers in Japan,” said Carol Lou, QDC’s President. “We believe that SCB will also be of invaluable assistance to us in setting up corporate partnerships in Japan.” Direct product sales and corporate partnering are the two key elements of QDC’s commercialization strategy.
Qdot™ nanocrystals, or quantum dots, are nanometer sized semiconductor crystals that brightly light up specific biological events. These nano-scale molecular light emitting diodes (LEDs) allow rapid, parallel, and ultra-sensitive detection of biomolecular interactions.
SCB is a wholly-owned subsidiary of Sumitomo Corporation, which is one of the largest trading companies in Japan. SCB’s primary mission is to provide Japanese life science researchers with efficient and competitive tools for drug discovery. SCB has established global networks with biotechnology venture companies and pharmaceutical companies worldwide. Additional information about SCB can be found at www.scbio.co.jp.
Founded in 1998, Quantum Dot Corporation is located in Hayward, CA. The company and its advisors are the world's leading experts in Qdot™ semiconductor nanocrystal technology and its applications. QDC sells and markets products to life science researchers worldwide. Additional information about QDC can be found at www.qdots.com.
For further information, please contact:
Quantum Dot: Andy Watson at email@example.com or call (510) 887-8775.
SC BioSciences Corporation: Goro Ishimoto at firstname.lastname@example.org or call +81-3-5777-6668
Quantum Dot Corporation
Illuminating the path to scientific discovery™
If you have a comment, please